Peri-Implant Therapy for the Dental Hygienist. Susan S. Wingrove

Чтение книги онлайн.

Читать онлайн книгу Peri-Implant Therapy for the Dental Hygienist - Susan S. Wingrove страница 20

Peri-Implant Therapy for the Dental Hygienist - Susan S. Wingrove

Скачать книгу

Scannapieco FA, Bush RM, Paju S Periodontal disease as a risk factor for adverse pregnancy outcomes; a systemic review. Ann Periodontol. 2003; 8: 70–78.

      7 7. Han YW, Redline RW, Li M, et al. Fusobacterium nucleatum induces premature and term stillbirth in pregnant mice; implication of oral bacteria in preterm birth. Infect Immun. 2004; 72: 2272–2279.

      8 8. Naujokat H, Kunzendorf B, Wiltfang J Dental implants and diabetes mellitus‐ a systematic review. Inter J of Implant Dent. 2016; 2: 5.

      9 9. Scannapieco FA, Papandonatos GD, Dunford RG Association between oral conditions and respiratory disease in a national sample survey population. Ann Periodontol. 1998; 3: 251–256.

      10 10. Azarpazhooh A, Leake JL Systematic review of the association between respiratory diseases and oral health. J Periodontol. 2006; 77: 1465–1482.

      11 11. Garcia RI, Nunn ME, Vokonas PS Epidemiologic associations between periodontal disease and chronic obstructive pulmonary disease. Ann Periodontol. 2001; 6: 71–77.

      12 12. Terpenning MS The relationship between infections and chronic respiratory diseases: an overview. Ann Periodontol. 2001; 6: 66–70.

      13 13. Rose LR, Mealey BL, Genco RJ, et al. Periodontics: Medicine, Surgery, and Implants. St. Louis, MO: CV Mosby, 2004: 848.

      14 14. Noack B, Genco RJ, Trevisan M, et al. Periodontal infections contribute to elevated systemic C‐reactive protein level. J Periodontol. 2001; 72: 1221–1227.

      15 15. Ridker PM, Rifai N, Rose L, et al. Comparison of C‐reactive protein and low‐density lipoprotein, cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002; 347(20): 1557–1565.

      16 16. Persson GR, Mancl LA, Martin J, et al. Assessing periodontal disease risk: a comparison of clinicians’ assessment versus a computerized tool. J Am Dent Assoc. 2003; 134: 575–582.

      17 17. Rohlfing CL, Wiedmeyer HM, Little RR, et al. Defining the relationship between plasma glucose and HbA (1c): analysis of glucose profiles and HbA (1c) in the Diabetes Control and Complications Trial. Diabetes Care. 2002; 25: 275–278.

      18 18. Diabetes Fact sheet N 312. World Health Organization. August 2011.

      19 19. Schwarz F, Derks J, Monje A, Wang H Peri‐implantitis 2017 world workshop. J Periodontol. 2018; 89(Suppl 1): S267–S290.

      20 20. Nishimua F, Takahshi K, Kunhara M, et al. Periodontal disease as a complication of diabetes mellitus. Ann Periodontal. 1998; 3: 20–29.

      21 21. Ryan ME, Carnu A, Kramer A The influence of diabetes on the periodontal tissues. J Am Dent Assoc. 2003; 134: 345–405.

      22 22. Mealey BL, Oates TW For the American Academy of Periodontology: diabetes mellitus and periodontal diseases. J Periodontol. 2006; 77: 1289–1303.

      23 23. Nelson RG, Shlossman M, Budding LM, et al. Periodontal disease and NIDDM in Pima Indians. Diabetes Care. 1990; 13: 836–840.

      24 24. Diabetes and periodontal diseases [position paper] Committee on Research, Science and Therapy. American Academy of Periodontology. J Periodontol. 2000; 71: 664–678.

      25 25. Liu R, Bal HS, Desta T, et al. Diabetes enhances periodontal bone loss through enhanced resorption and diminished bone formation. J Dent Res. 2006; 85: 510–514.

      26 26. Taylor GW Bidirectional interrelationships between diabetes and periodontal diseases: an epidemiologic perspective. Ann Periodontol. 2001; 6: 99–112.

      27 27. Mercado FB, Marshall RI, Bartold PM Interrelationships between rheumatoid arthritis and periodontal disease: a review. J Clin Periodontol. 2003; 30: 761–772.

      28 28. Persson RE, Hollender LG, Powell LV, et al. Assessment of periodontal conditions and systemic disease in older subjects. I. Focus on osteoporosis. J Clin Periodontol. 2002; 29: 796–802.

      29 29. Kondo K, Niino M, Shido K A case‐control study of Alzheimer’s disease in Japan: significance of lifestyles. Dementia. 1994; 5: 314–326.

      30 30. Gatz M, Mortimer JA, Fratiglioni L, et al. Potentially modifiable risk factors for dementia in identical twins. Alzheimers Dementia. 2006; 2: 110–117.

      31 31. Stein PS, Scheff S, Dawson DR III Alzheimer’s disease and periodontal disease: mechanisms underlying a potential bi‐directional relationship. Grand Rounds Oral‐Sys Med. 2006; 1: 14–24.

      32 32. Azuma M Fundamental mechanisms of host immune responses to infection. J Periodontal Res. 2006; 41: 361–373.

      33 33. Ginde AA, Liu MC, Camargo CA Demographic differences and trends of vitamin Dinsufficiency in the US population, 1988‐2004. Arch Intern Med. 2009; 169(6): 626–632.

      34 34. Choukroun J, Khoury G, Khoury F, et al. Two neglected biologic risk factors in bone grafting andimplantology: high low‐density lipoprotein cholesterol and low serum vitamin D. J Oral Implantol. 2014; 40(1): 110–114.

      35 35. Burt LA, Billington EO, Rose MS, Raymond DA, Hanley DA, Boyd SK Effect of high‐dose vitamin D supplementation on volumetric bone density and bone strength:a randomized clinical trial. JAMA. 2019; 322(8): 736–745. https://doi.org/10.1001/jama.2019.11889.

      36 36. Lamster IB, Lalla E Periodontal medicine: changing the face of dental care. Dimens Dent Hyg. 2004; 2(4): 10–14.

      37 37. Osteoporosis medications and your dental health. Pamphlet W418, American Dental Association/National Osteoporosis Foundation, 2008.

      38 38. AAOMS Updates Medication‐Related Osteonecrosis of the Jaw 2014 Update of 2009 Position Paper by Special Committee.

      39 39. National Osteoporosis Foundation. America’s bone health: The state of osteoporosis and low bone mass in our nation. Washington (DC): National Osteoporosis Foundation; 2002./Bone Health and Osteoporosis: A Report of the Surgeon General. https://www.ncbi.nlm.nih.gov/books/NBK45515

      40 40. Nase JB, Suzuki JB Osteonecrosis of the jaw and oral bisphosphonate treatment. J Am Dent Assoc. 2006; 137(8): 1115–1119.

      41 41. Medical News Today AAOMS Updates BRONJ Position Paper January 23, 2009.

      42 42. Misch CE. Contemporary Implant Dentistry, Vol. 456, 2nd ed. St Louis, MO: Mosby, 1999.

      43 43. Cartsos VM, Zhu S, Zavras AI Bisphosphonate use and risk of adverse jaw outcomes. J Am Dent Assoc. 2008; 139(1): 23–30.

      44 44. McDonald E, Marino C Dry mouth: diagnosing and treating its multiple causes. Geriatrics. 1991; 46: 61–63.

      45 45. Almeida D, Vianna K, Arriaga P, Moraschini V Dental implants in Sjogren’s syndrome patients: a systematic review. PLoS One. 2017; 12(12): e0189507.

      46 46. Berglundh T, Lindhe J, Lang NP, et al. Mucositis and peri‐implantitis. In: Clinical Periodontology and Implant Dentistry. 4th ed. Copenhagen: Blackwell Publishing/Munksgaard, 2003.

      47 47. Lee CT, Huang YW, Zhu L, Weltman R Prevalences of peri‐implantitis and peri‐implant mucositis: systematic review and meta‐analysis. J Dent. 2017; 62: 1–12.

      Конец

Скачать книгу